SCHEMBL8993

SCHEMBL8993

Nc1ncnc2c1ncn2CCCc1oc2ccccc2c(=O)c1-c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 3/20 0.44
NSD3 Q9BZ95 2/20 0.44
PIK3CD O00329 7/20 0.43
ADORA2A P29274 3/20 0.42
PI4KA P42356 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PIK3CG P48736 2/20 0.39
EGFR P00533 1/20 0.39
PIK3R1 P27986 1/20 0.38
CSNK1E P49674 1/20 0.38
ADCY5 O95622 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8575 0.95 ADORA2A (0.46) NSD2NSD3PIK3CDADORA2API4KA
SCHEMBL9275 0.91 NSD2 (0.47) NSD2NSD3ADORA2API4KAPI4K2B
SCHEMBL9179 0.91 ADORA2A (0.47) NSD2NSD3PIK3CDADORA2API4KA
SCHEMBL9569 0.90 ADORA2A (0.50) NSD2NSD3PIK3CDADORA2API4KA
SCHEMBL8770 0.90 NSD2 (0.47) NSD2NSD3PIK3CDADORA2API4KA
SCHEMBL30013691 0.90 PIK3CD (0.46) NSD2NSD3PIK3CDADORA2API4KA
SCHEMBL8426 0.90 PIK3CD (0.46) NSD2NSD3PIK3CDADORA2API4KA
SCHEMBL8842 0.88 ADORA2A (0.47) NSD2NSD3ADORA2API4KAPI4K2B
SCHEMBL8117 0.86 ADORA2A (0.49) NSD2NSD3ADORA2API4KAPI4K2B
SCHEMBL8479 0.85 ADORA2A (0.44) NSD2NSD3PIK3CDADORA2API4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 EP claimed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO claimed
EP-4292596-A1 METHOD AND COMBINATION FOR TREATING TUMORS Curon Biopharmaceutical (Shanghai) Co., Limited (CN) 2023-12-20 EP disclosed
EP-2916868-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR Rhizen Pharmaceuticals S.A. (CH) 2015-09-16 EP disclosed
WO-2014072937-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR RHIZEN PHARMACEUTICALS SA (CH) 2014-05-15 WO disclosed
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 EP disclosed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO disclosed